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The effect o f  t rea tm en t  with in ter leukin -8 (IL-8 ), a neutrophil-activating cytokine,  was investigated in 
normal  and neutropenic  mice infected with a lethal dose of Pseudomonas aeruginosa, Klebsiella pneumoniae , or  
Plasmodium berghei. In t raper i tonea l  (i.p.) IL -8 t rea tm ent  was associated with accelerated death when IL -8 was 
adminis te red  shortly before i .p. infection with P. aeruginosa o r  shortly af ter  i.p. infection with P. aeruginosa 
and K. pneumoniae. Histopathological  analyses demonstra ted  a tendency to more severe o rgan  lesions in 
IL-8 - treated mice. Only nonneutropen ic  mice that  received IL -8 shortly before the infectious challenge and at 
the site of  infection were  protected by IL-8 . W h e th e r  IL -8 is protective o f  o r  de tr imenta l  to the survival of 
infection appea red  to depend on the presence of bacteria  at the injection site and  on the presence of 
neutropenia .  IL -8 may be an im por tan t  par t ic ipant  in the cascade of interacting cytokines that  is induced by 
the lethal infectious challenge.
In te r leuk in -8 (IL-S) is an S-kDa po lypep t ide  that is p ro ­
duced  by a wide  v a r ie ty  o f  cell types  upon  s t imula t ion  by 
cy tok in es  like I L -1 and  tu m o r  nec ros is  fac tor  a lpha and by 
en d o tox in  and lectins (9, 17, 20; for a rev iew ,  sec reference  
21). IL -8 is a c h e m o a t t r a c t a n t  for neu t roph i ls ,  T  ly m p h o ­
cy te s ,  and basoph i ls  and leads to ex p res s io n  of  adhes ion  
m olecu les ,  ox ida t ive  bu rs t ,  and  deg ranu la t ion  in neutrophi ls  
(5, 12, 17, 21).
We have  p rev iou s ly  sh o w n  that  t r e a tm en t  o f  both  n e u t ro ­
penic  and normal  mice with  low d o ses  o f  IL-1 (3 fig/kg of  
body  weight)  24 h before  an infection with  g ram -negat ive  
bac te r ia  e n h a n c e s  surv iva l  (22, 23). Also ,  p ro tec t ion  against 
lethal murine  malaria  has  been  ob ta ined  with low doses  of  
IL-1 (3). T he  exac t  m e c h a n ism  o f  this p ro tec t ion  is still 
unc lear ,  but  s ince IL-1 induces  I L -8 (14, 17, 21), we inves­
tigated the effect o f  I L -8 in lethal bacter ia l  infect ions in 
both  n eu t rop en ic  and  norm al  mice and in mice with malaria 
in o rd e r  to find out  w h e th e r  I L -8 has  a the rapeu t ic  p o te n ­
tial.
M A T E R IA L S  AND M E T H O D S
Cytokines.  R eco m b in an t  hu m an  I L -8 w as  p repa red  at 
S a n d o z  R esea rch  Ins t i tu te ,  V ienna ,  Austr ia  (13). The  e n d o ­
toxin co n ten t  o f  this p re p a ra t io n  w as  less than 0.15 ng/mg. 
H u m a n  I L -8 w a s  used  b ecau se  a m urine  analog (p resum ably  
m a c ro p h a g e  in f lam m atory  prote in  2 [25]) w a s  not available.  
A l though  I L -8 is a hum an  cy tok ine  which  has  a cer ta in  
spec ie s  specif icity (19), it has  been  show n  to be effective in 
mice  (7). R eco m b in a n t  hum an  IL-1(3 w a s  kindly p rov ided  by 
P. G r a b e r  (G laxo ,  G e n e v a ,  Sw itzer land) .  The  endo tox in  
c o n te n t  o f  this p rep a ra t ion  w a s  less than 1.53 ng/mg. The 
c y to k in e s  w e re  s to red  at - 8 0 ° C  and w ere  diluted im m ed i­
a te ly  be fo re  use in pyrogen-f ree  phospha te -buffe red  saline 
(PBS) with  2% (vol/vol) m ouse  se rum .
* C o r re sp o n d in g  au thor .
Mice. Fem ale  o u tb red  Swiss  mice (weight ,  20 to 25 g; 
T N O ,  Rijswijk, The  N e the r land s )  w ere  used  in the bacter ia l  
infection s tudies .  F em a le  inbred C57BL/6J  mice (weight ,  20 
to 25 g; from a local co lony)  w ere  used in the malaria  
expe r im en ts .  T he  mice w ere  a l lowed to acc l im at ize  for 6 
days  and w ere  kept  u n d e r  spec if ic -pa thogen-free  cond i t ions .  
S tandard  lab ch o w  (R M H -T M ;  H o p e  F a rm s ,  W o c rd e n ,  T he  
N e the r lands )  and acidified w a te r  w ere  available  ad libitum. 
N eu t ro p en ic  mice rece ived  i r radia ted  food.
Infections. F o r  survival  e x p e r im e n ts ,  mice w e re  infected  
with 0.5 x 1 0 7 to 1 x  107 C F U  o f  P seudom onas  aeruginosa  
A T C C  27853 in t ram uscu la r ly  (i .m.) in the right thigh muscle  
or  in t raper i tonea l ly  (i.p.) on day  0. Since P. aeruginosa  docs  
not kill normal mice,  micc w ere  m ade  n e u t ro p e n ic  (< 0 .5  x 
10w neutrophi ls  per  liter) by two s u b c u ta n e o u s  inject ions  of  
c y c lo p h o sp h a m id e  (150 mg/kg; A S T A  P h a rm a ,  F rank fu r t ,  
G erm any)  on day  - 4  and 100 mg/kg on d ay  - 1 .  In a n u m b e r  
of  ex p e r im en ts ,  micc infected with 1 x  10'’ to 5 x \0 h C F U  
of Klebsiella pneum on iae  A T C C  43816 w ere  m ade  n e u t ro ­
penic to a lesser  ex ten t  (0.8  x 10g to 2 x  10c; neu t roph i ls  per  
liter) by giving them  150 mg o f  c y c lo p h o sp h a m id e  per  kg on 
day — 1. N o n n e u t ro p e n ic  mice w ere  also infected with  K. 
pneum oniae .  All bacter ia l  cha l lenges  (0.1 ml per  m ouse)  
w ere  p repa red  by ap p rop r ia te  dilution of  overn igh t  cu l tu res  
w ash ed  three  t imes  in sal ine.  C y to k in e s  w ere  given i.p. at 
severa l  time points .  Six ho u rs  af ter  infect ion,  gcn tam ic in  
(120 mg/kg; Schcr ing ,  K en i lw or th ,  N .J . )  w a s  adm in is te red  
su b cu ta n e o u s ly  in o rd e r  to p o s tp o n e  the time of  dea th  and 
thus  accen tu a te  the d ifferences  b e tw een  t r e a tm e n t  g roups .  
Mortal i ty  w as  reco rd ed  for at least 48 h. Since IL -8 is heat  
s table ,  control  an imals  rece ived  80 ng of  hea t - inac t iva ted  
(90°C for 30 min) IL-1 ins tead  of  IL -8 . F o r  malar ia  e x p e r i ­
m ents ,  1,000 e ry th ro c y te s  paras i t ized  with Plasm odium  
berghei  K173 w ere  injected i.p. as d esc r ib ed  e l se w h e re  (4). 
Paras i temia  w as  d e te rm in ed  in M ay -G ru n w a ld  G iem sa-  
s ta incd thin b lood films m ade  from a d rop  o f  tail b lood .  
Morta l i ty  w as  sco red  twice daily. Micc that  s u c c u m b e d  to 
infection w ere  p ro c e s se d  for h is topa tho logy .
Differential counts of  leukocytes. Thin  b lood films from tail
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FIG .  1. (A) Survival of  neu tropen ic  Swiss  mice af ter  t rea tm en t  
with 800 ng o f  IL-8 given i.p. 24 or  0.5 h before or  6 h after infection 
with 0.5 x 107 to 1 x 107 C'FU of P. aeruginosa in the right thigh 
m uscle .  C ontro l  mice received  heat- inac t iva ted  (90°C for 30 min) 
IL-1. E ach  t rea tm en t  group cons is ted  o f  at least 90 mice. The 
d ifferences b e tw een  the g roups  w ere  not significant. (B) An e x p e r ­
iment similar to that for panel A perfo rm ed  with P. aeruginosa 
injected i.p. Results  are from three independen t  ex p e r im en ts ;  each 
t rea tm en t  g roup  cons is ted  of  at least 30 mice. Survival o f  mice 
that rece ived  IL-8 24 h before  infection did not differ from that of  
mice in the contro l  g roup .  Death  in the mice that rece ived  IL-8 0.5 
h before  or 6 h af ter  infection w as  significantly acce le ra ted  (P < 
0.001).
blood w ere  s ta ined  with M a y -G ru n w a ld -G ie m s a ’s so lu t ion .  
Blood w a s  taken  from e th e r -a n e s th e t iz e d  mice by orbital  or  
hear t  p u n c tu re  and w as  p laced  in E D T A .  Five milliliters of 
ice-cold PBS with 0 .38% (wt/vol) sod ium  ci t ra te  w a s  injected 
into the per i tonea l  cav i ty  o f  mice that w e re  killed by cervical  
d is loca t ion .  A f te r  m assage  o f  the a b d o m e n ,  the per i toneal  
cells w e re  a sp i ra ted  and  c o u n te d  by  flow c y to m e t ry  (H - l ;  
T e c h n ic o n  In s t ru m e n ts  C o rp o ra t io n ,  T a r ry to w n ,  N .Y .) .  Cy- 
tocen tr i fuge  p re p a ra t io n s  o f  the per i tonea l  cells  w e re  s ta ined  
with M a y - G r u n w a ld - G ie m s a ’s so lu t ion .  Differential  c o u n ts  
of  b lood and per i tonea l  cells  w e re  p e r fo rm ed  in dup l ica te  on 
200  nuc lea ted  cells.
Bacterial counts. P. aeruginosa  and K. p n eu m o n ia e  w ere  
cu l tu red  at 37°C in brain hear t  infusion b ro th  with va r ious  
c o n c e n t r a t io n s  o f  I L -8 or  vehic le  (PBS).  At 2, 3, 4, and  5 h 
af ter  inocula t ion ,  100 jjlI of  10-fold serial  d i lu t ions  w ere  
p la ted in dupl ica te  on b lood agar  to d e te rm in e  bacter ia l  
coun ts .
In the a s s e s s m e n t  o f  the effect o f  I L -8 on bacter ia l  
o u tg ro w th  in v ivo ,  mice w e re  a n es th e t iz ed  with e the r ,  b led,  
and killed by cervical  d is loca t ion .  O rgans  w e re  rem o v e d  
asep t ica l ly ,  w e ighed ,  and h o m o g e n iz ed  with an U l t r a tu r ra x  
(Janke  & K u n k e l ,  S tau fen ,  G e rm a n y )  in steri le sal ine;  10 o r
20 \x\ o f  10-fold serial d i lut ions w a s  incuba ted  overn igh t  at 
37°C, and the n u m b e r  o f  C F U  w a s  d e te rm in ed .
Histology. O b s e rv e r -m a s k e d  h is topa tho logy  w a s  p e r ­
fo rm ed  on mice sacrif iced 30 h af ter  i.p. P. aeruginosa  
chal lenge  and on mice tha t  died af ter  P. berghei  infection.  
T he  f req u en cy  o f  an im als  with  h e m o r rh a g e s ,  the f r eq u en cy  
o f  h e m o r rh a g e s  in an organ  o f  a given an imal ,  as well as the 
s ize o f  the h e m o r rh a g e s  w e re  sco red  in the v a r io u s  e x p e r i ­
menta l  g roups .
Statistics. Surv ival  w a s  ana lyzed  by use o f  the log rank  test  
(16), bac ter ia l  c o u n t s  w e re  an a ly zed  by using o n e -w a y  
ana lys is  o f  v a r ia n ce  o r  the G eh an  W ilcoxon  test  (depend ing  
on the cen so r in g  o f  da ta ) ,  and  differential l eukocy te  c o u n ts  
w e re  ana lyzed  by  the K ru sk a l  Wallis  test  (11). P  v a lu e s  of  
<0 .05  w e re  co n s id e re d  s ta t is t ical ly  significant.
RESULTS
IL-8 in P. aeruginosa infection. W hen  P. aeruginosa  w as  
adm in is te red  i .m. to n eu t rop en ic  mice ,  a single dose  of  800 
ng of  IL -8 , given i.p. 24 o r  0.5 h before  or  6 h af ter  infect ion,  
did not significantly influence the survival  of  mice (Fig. 1A). 
Similar  resu l ts  w e re  found with lower  doses .  Since no 
toxici ty  w a s  o b se rv e d  w h en  800 ng w as  given to non in fec ted  
normal  and n eu t ro p en ic  mice,  this dose  w as  used  in fur ther  
ex p e r im en ts .  H o w e v e r ,  as sh o w n  in Fig. IB ,  i.p. injection of 
P. aeruginosa  resu l ted  in a significant e n h a n c e m e n t  o f  the 
dea th  rate if I L -8 w a s  given 0.5 h before  o r  6 h af ter  infection 
(X2 =  5.96 and P  < 0.05, and x 2 =  6.69 and P  < 0.01, 
respec t ive ly) .  A dm in is t ra t ion  of  I L -8 24 h before  infection 
did not affect survival .  IL-1(3 (800 ng given i.p.) significantly 
e n h a n c e d  survival  in mice infected i .m. and i.p. (data  not 
show n) .
K. pneumoniae  infection. In normal  and n eu t ro pen ic  mice ,  
I L -8 adm in is te red  i.p. 24 or  0.5 h before  or  6 h af ter  i.m. 
chal lenge with  K. p n eu m o n ia e  had no effect on survival  (Fig. 
2A and B). In the case  o f  the i.p. rou te  o f  infect ion,  h o w ev e r ,  
the dea th  rate  w a s  e n h a n c e d  by  i.p. I L -8 adm in is t ra t ion  6 h 
af ter  the chal lenge (in normal  mice,  x 2 =  8.62 and P  < 0.005; 
in n e u t ro p en ic  mice,  x 2 =  4.26 and P < 0.05) (Fig. 2C and 
D). In co n t ra s t ,  I L -8 given to normal  mice 0.5 h before  the 
in t raper i tonea l  chal lenge resu l ted  in a rep roduc ib le  p ro tec-  
tive effect in normal  mice (x" =  12.17 and P  < 0.001) but  not 
in n eu t ro p en ic  mice.
Table  1 su m m a r iz e s  the cond i t ions  and the o u tc o m e s  of  
m ouse  survival  af ter  the bacter ia l  chal lenges .
P. berghei infection. Six daily inject ions of  800 ng of  I L -8 
s tar t ing  on the day  of  i.p. infection did not a l ter  the degree  of 
pa ras i tem ia  o r  the dea th  rate  af ter  infection (data  not 
show n) .
Effects of IL-8 on bacterial growth in vivo and in vitro. T o
exam ine  w h e th e r  the effects  of  I L -8 w e re  due  to e n h a n c e d  
bacter ia l  g ro w th ,  bacter ia l  c o u n ts  in the b lood ,  l ivers, 
sp leens ,  k idneys ,  and thigh m usc les  o f  the mice in each 
t r ea tm en t  g roup  w e re  d e te rm in ed  30 h af ter  the bacter ia l  
infection,  a time point  at w h ich  there  w a s  a c lear  difference 
in survival  b e tw een  the g roups .  N o  significant d ifferences  
in bacter ia l  c o u n ts  w ere  o b se rv e d  in any  t r e a tm e n t  g roup  
o f  mice infected with  P. aeruginosa  i .m. or  i.p. and  K. 
p n eu m o n ia e  i.p. (eight mice per  g roup;  da ta  not show n) .  
We also ex am in ed  w h e th e r  I L -8 e n h a n c e d  mult ipl icat ion of 
P. aeruginosa  and K. p n eu m o n ia e  in cu l tu re ,  b ecau se  som e 
pa thogen ic  bac te r ia  use cy to k in es  as g row th  fac to rs  (18). 
At c o n c e n t ra t io n s  from 0.1 to 1,000 ng of  I L -8 pe r  ml, no 
effect o f  I L -8 on bac ter ia l  g row th  w a s  d e tec ted  (data  not 
show n) .
Blood and peritoneal leukocytes. T he  n u m b e rs  o f  per i tonea l  
leu k ocy tes  in n eu t ro p en ic  mice w ere  a s se s se d  30 h af ter  i.p. 
or  i .m. P. aeruginosa  infect ion,  a t ime point  at w h ich  a 
m axim al  d ifference in survival  b e tw e e n  the t r e a tm e n t  g roups  
w a s  o b s e rv e d .  T h e  per i tonea l  g ran u lo cy te  and m ac ro p h ag e  
n u m b e rs  did not differ b e tw e e n  IL -8 - t rea ted  and con tro l  
infected mice;  the total leukocy te  cou n t  and the n u m b e r  of 
b lood  g ran u lo cy te s  did not differ e i ther .
In norm al  mice infec ted  i.p. wi th  K. p n e u m o n ia e , total 
and differential l eukocy te  c o u n ts  o f  b lood  and  per i tonea l  
fluid at 30 h a f te r  infection did not  differ significantly 
b e tw e e n  IL -8 - t rea ted  and  con tro l  infected mice (da ta  not  
show n) .
Histology. Histo log ic  ana lyses  w e re  p e r fo rm e d  on the 
o rgans  o f  mice killed 30 h af ter  infect ion with  P. aeruginosa  
for the r e a so n s  d e sc r ib ed  above .  H e m o r r h a g e s  w e re  found in
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FIG . 2. (A) Survival of  normal Swiss mice that received 800 n g o f  
IL-8 given i.p. 24 or 0.5 h before or 6 h after infection with 1 x 10*’ to 
5 x 10(> C F U  o f  K. pneumoniae in the right thigh muscle. Control 
mice received heat-inactivated (90°C for 30 min) IL-1. Each treatment 
g roup  consisted of 60 mice. T h e  differences between the groups were 
not significant. (B) The sam e experiment as that for panel A p e r ­
formed in neutropenic  mice (at least 70 mice per  group); differences 
w ere  not significant. (C) Survival o f  normal Swiss mice that received 
800 ng o f  IL-8 given i.p. 24 or 0.5 h before or 6 h a l ter  i.p. infection 
with 1 x 10° to 5 x 10'’ C F U  of A*, pneumoniae. Each treatment group 
consis ted  of  at least 125 mice. Administration o f  800 ng of  IL-8 i.p. 6 
h after infection resulted in a statistically significant deteriorating 
effect (x2 =  8.62 and P < 0.005). Mice that received IL-8 i.p. 0.5 h 
before the challenge w ere  pro tected  (\'2 = 12.17 and P < 0.001). (D) 
The  sam e exper im ent  as that for panel C performed in neutropenic  
mice. The survival of  mice (at least 40 mice per group) that received
the bra ins ,  l ivers, sp leens ,  k idneys ,  and  lungs o f  mice 
infected with P. aerug inosa . In m os t  o rgans ,  no c lear  
differences b e tw een  the t rea tm en t  g roups  w ere  p resen t .  
Pe lech iae  w ere  m ore  f requent  in the lungs of  the contro l  
g roup  (seven of  eight mice in the contro l  g roup  v e r s u s  three  
of  eight mice in the IL-S-trcated  group).  E x tens ive  h e m o r ­
rhages w ere  m ore  frequent ly  o b se rv e d ,  h o w e v e r ,  in the 
bra ins  o f  IL -8 - t rea ted  micc than in those  of  con tro l  mice 
(four of eight animals  v e r s u s  one  of seven  animals ,  r e s p e c ­
tively) (Fig. 3).
In mice with  P. berghei  infect ions,  h is topa tho logy  c o n ­
firmed that I L -8 did not p reven t  the d e v e lo p m en t  o f  cerebra l  
malaria ,  in con t ra s t  to IL-1 t rea tm en t  (3). All mice that died 
within 2 w e e k s  af ter  infection exhib i ted  h em o rrh ag es  in their  
bra ins ,  and these  tended  to be m ore  frequent  and m ore  
severe  in IL -8 - t rea ted  animals .  Pathological  changes  in o the r  
o rgans  w ere  similar in both  t rea tm en t  g roups .
DISCUSSION
W h e re a s  IL-1 t rea tm en t  s t rongly  e n h a n c e s  the survival  of  
normal and n eu t ro pen ic  mice that are Icthally infected (3, 4, 
15, 22-24),  IL -8 adm in is te red  i.p. did not p ro tec t  mice u n d e r  
most  test cond i t ions  applied in the p resen t  s tudy .  I L -8 did 
not significantly change  the survival  rate  in mice with  i.m. 
infect ions with P. aeruginosa  and A', p n e u m o n ia e . S u rp r i s ­
ingly, survival  and  m orb id i ty  m ay  even  be negat ively  af­
fected by I L -8 in micc with  i.p. infections.  Af ter  i.p. infec­
tion with P. aerug inosa , s ignificantly en h a n c ed  morta l i ty  
w as  o b se rv e d  in n eu t ro p en ic  mice that  rece ived  I L -8 shor t ly  
before  o r  6 h af ter  infection.  T he  findings in mice infected 
with  A', pneum oniae  i.p. w e re  part ial ly different.  Micc 
t rea ted  with I L -8 6 h af ter  infection also did w orse  than 
con tro ls .  The  sam e  w a s  found for n eu t ro p en ic  micc which  
rece ived  IL -8 0.5 h before  infection,  but normal  mice w ere  
p ro tec ted  by this t r ea tm en t .  In mice with P. berghei  infec­
t ions,  no effect o f  IL -8 w a s  found on survival  or  pa ras i tem ia ,  
but  histological ana lyses  indicated that IL -8 t r ea tm en t  e n ­
hanced  the d e v e lo p m en t  of  ce rebra l  malaria.
T he  different resul ts  ob ta ined  b e tw een  mice with  i.m. and 
i.p. bacter ia l  infect ions suggest  that acce le ra t ion  of  dea th  
o c c u r s  if both  I L -8 and bac ter ia  are p resen t  at the sam e  site.  
B e c a u se  the acce lera t ion  of  dea th  o c c u rs  only  if I L -8 is 
adm in is te red  shor t ly  before  o r  af ter  the infect ious  cha l lenge ,  
the effect of  I L -8 s e e m s  to be fast and short- l ived .  It is 
intriguing that the de le te r ious  effects w ere  most  p rom inen t  
w h e n  there  w as  neu tropen ia .
T he  de le te r ious  effect o f  I L -8 could  not be exp la ined  by an 
e n h a n c e d  multipl icat ion of  bac te r ia .  A cce le ra ted  dea th  
might be expla ined  by the c h e m o tac t ic  effect o f  I L -8 on 
neu troph i ls ,  with the su b se q u e n t  re lease  of s e c re to ry  p r o d ­
ucts  that  cause  tissue dam age ,  con tr ibu t ing  to dea th  (1). If an 
IL -8-evoked  neutrophi l  re sponse  w ere  the exp lana t ion ,  one 
w ould  expec t  to find more  o b v io u s  effects  o f  I L -8 in non- 
n eu t ropen ic  ra the r  than n eu t ro p en ic  micc ,  but this w a s  not 
the case .  A similar,  v e ry  low n u m b e r  o f  neu t roph i ls  in the 
per i toneal  cavi t ies  of the IL -8 - t rea ted  g roup  and the contro l  
g roup  also argues  against  such  a m ech an ism .
IL-8 i.p. at 24 h before i.p. infection did not differ from that of  mice 
in the control  group.  Death  in the mice that received  IL-8 i.p. 0.5 h 
before or  6 h after  infection w a s  significantly acce le ra ted  ( \ 2 = 3.46 
and / J =  0.05, and \ 2 = 4.26 and P < 0.05, respectively) .
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T A B L E  1. Condit ions  and survival  ou tcom e  after bacteria l  challenges
B ac te r ia R ou te  o f  bac te r ia l  
adm in is t ra t ion
Effect on 
surv iva l
P o ly m o rp h o n u c le a r  
leu k o cy te  cond i t ion
Figure
no.
T im e  (h) IL-8 w a s  
g iven  be fo re  o r  af ter  
bac te r ia l  cha l lenge
P. aeruginosa i.m. N one N eu tropen ic 1A - 2 4 ,  - 0 . 5 ,  + 6
P. aeruginosa i . p . Detr imental N eu tropen ic IB —0.5, + 6
K. pneumoniae i.m. N one N orm al 2A - 2 4 ,  - 0 . 5 ,  + 6
K. pneumoniae i.m. N one N eu tropen ic 2B - 2 4 ,  - 0 . 5 ,  + 6
K. pneumoniae i.p. Detr imental N orm al 2C + 6
K. pneumoniae i . p . Protective N orm al 2C - 0 . 5
K. pneumoniae i.p. Detr imental N eu tropen ic 2D - 0 . 5 ,  + 6
Since c y c lo p h o sp h a m id e ,  which  w as  used in o u r  s tudy  to 
induce n eu t ro p en ia ,  also s t rongly  affects m o n o cy to p o ie s i s ,  
the effects  o f  I L -8 on m o n o c y te s  are p robab ly  not r e sp o n s i ­
ble c i ther .  In addi t ion ,  the n u m b e rs  o f  per i toneal  m a c r o ­
phages  w ere  also vir tual ly  identical in IL -8 - t rca tcd  and 
con tro l  mice.
A possible  m echan ism  of  the e n h a n c e m e n t  of dea th  after 
I L -8 adm in is t ra t ion  is the par t ic ipa t ion  of  I L -8 in the lethal 
cy tok in em ia ,  the o v e r s h o o t  o f  cy tok ine  p roduc t ion  which  is 
thought  to m ed ia te  most  s y m p to m s  of  se r ious  infect ions and 
which  we think is am el io ra ted  by p rec x p o su re  to IL-1 (22). 
In o th e r  w o rd s ,  I L -8 adm in is te red  i.p. could  act synergist i-  
cally with the de le te r ious  effects  o f  o th e r  cy to k ines  and 
m ed ia to rs  like tu m o r  necros is  factor ,  IL-1, g a m m a  in ter­
feron,  p la te le t-ac t iva t ing  fac tor ,  and leuko tr icnc  B4 induced 
by g ram -negat ive  bac te r ia  adm in is te red  i.p. (6 ). S ince h e m ­
o r rhages  and o th e r  pathological  ch an g es  arc similar in mice 
with  cerebra l  malar ia  and mice cha l lenged  with a lethal dose  
o f  bac te r ia ,  a c o m m o n  lethal p a th w a y  in w hich  these  c y to ­
kines are involved can be a ssum ed .  T he  o b se rv a t io n  that  
IL -8 - t rea tcd  an imals  had m ore  p ro n o u n c e d  brain h e m o r ­
rhages  w ou ld  be in ag reem en t  with the hypo thes is  p re sen ted
above  and with the findings o f  Colditz  et al. (2) show ing  
p lasma leakage af ter  I L -8 adm in is t ra t ion .
T he  p ro tec t ive  effect of  I L -8 adm in is te red  to nonneu tro -  
penic  mice shor t ly  before  i.p. chal lenge with K. pneum on iae  
can be reconci led  with the la t ter  hypo thes is .  T he  adm in is ­
tered  I L -8 m ay  inhibit local neutrophi l  adhes ion  to e n d o th e ­
lial cells ac t iva ted  as a c o n s e q u e n c e  of  the bacter ia l  cha l ­
lenge,  thus  limiting inf lammatory  dam age  from a neutrophi l -  
endothel ia l  cell in teract ion (8 , 10). This  might explain the 
lack o f  d ifferences  in the leukocy te  and bacteria l  c o u n ts  that 
we found,  desp i te  the p ro tec t ive  effect of  I L -8 in this sett ing.  
A n o th e r  possible  exp lana t ion  is, that  unde r  the c i r c u m ­
s tan ce s  o f  the p re sen t  s tudy ,  I L -8 initially a t t rac ts  a suffi­
cient  n u m b e r  o f  neu troph i ls  to the right p lace and at the right 
time to be able to phagocy t ize  and d es t ro y  the adm in is te red  
m ic roo rgan ism s  to a cer ta in  ex ten t .  This  initial even t  might 
su p p re s s  the initiation o f  the c a sc a d e  of  lethal cy tok inem ia .  
This  hypo thes is  is not necessa r i ly  in conflict with the o b ­
se rved  similar neutrophi l  and bacter ia l  c o u n ts  at la ter  time 
points .  T h u s ,  ou r  resul ts  indicate  that  desp i te  its neutrophil-  
ac t iva t ing  effects repo r ted  in the l i te ra ture ,  I L -8 is a harmful 
molecule  u n d e r  a n u m b er  o f  expe r im en ta l  cond i t ions .  Such
FIG. 3. H em o rrh ag e s  and ghos ts  of  e ry th ro c y te s  in the brain of  an IL-8-treated  m ouse  3U h after infection with P. aeruginosa.
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de le te r ious  effects are also know n for o th e r  p ro in f lam m atory  
cy tok ines .  O u r  resul ts  argue against  a possible  role o f  IL-8 as 
a m ed ia to r  o f  the p ro tec t ive  effect of  IL-1 p re e x p o su re  in 
mice with infection.
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